LIFE-DSR Natural History Study Blood Biomarker Data Shared at CTAD
The yearly conference brings together leaders throughout the world who are dedicated to advancing treatment options for Alzheimer’s disease (AD).
December 23, 2020
The yearly conference brings together leaders throughout the world who are dedicated to advancing treatment options for Alzheimer’s disease (AD).
LuMind IDSC Foundation President/CEO Hampus Hillerstrom and Chief Scientific Officer James Hendrix acknowledged for their efforts on the T21RS COVID-19
November 12, 2020 1PM ET | 12 PM CT | 11 AM MT | 10 AM PT Learn about the
October 29, 2020 (Burlington, MA). LuMind IDSC Foundation today announced a new partnership with Eli Lilly and Company (Lilly) aimed
Kate and Addy share tips about keeping others safe from COVID-19. Source: Kate and Addy White
Boston, MA and New York, NY (July 14, 2020) – The LuMind IDSC Foundation and the National Down Syndrome Society (NDSS),
I recently had the pleasure of interviewing the Trisomy 21 Research Society (T21RS) COVID-19 Task Force members who launched a
We have been shocked and saddened by the events over the last week surrounding the tragic and brutal death of
Many hospitals have enacted “No Visitor” policies that prevent patients in the hospital from having family members or caregivers visit
PLYMOUTH, MINN., DENVER, BURLINGTON, MASS., ATLANTA, NEW YORK CITY, HAMDEN, CONN. March 27, 2020 – Today, an important Q&A on COVID-19